VIDEO: Canntab Therapeutics Ltd (CNSX:PILL) Cannabis Hard Tablet Delivery Mechanism

1,144 views · Published 28 September 2018 · 7:42 · Indexed 6 November 2026

Channel: Midas Letter · 2018 · News & Politics

Watch on YouTube

Canntab Therapeutics Ltd (CNSX:PILL) (OTCMKTS:TLFTF) (FRA:TBF1) CEO Jeff Renwick and CFO Richard Goldstein talk about the recent doubling of Canntab’s valuation. Canntab creates pain management products by utilizes resins to produce cannabis hard tablets for the medical market. Under current ACMPR rules, bud and oil are the only Health Canada-approved delivery methods but the pair is confident in the near future, hard tablets will also be declared an acceptable oral dose delivery mechanism. They compare hard tablets to softgels and Renwick indicates that the advantage of the hard tablet is it protects the cannabinoids from degradation. They discuss Canntab’s revenue model and Goldstein indicates the company expects to see revenue from product sales in 2019.

************************

Check out our website: 
https://midasletter.com

************************

SUBSCRIBE to our YouTube: 
http://bit.ly/MidasLetterYoutube 

SUBSCRIBE to our Newsletter:
http://bit.ly/MidasLetterNewsletter 

Download Our Podcast on iTunes:
http://bit.ly/MidasLetterPodcast

************************

Follow Us on Twitter: 
http://bit.ly/MidasLetterTwitter

Like Us on Instagram: 
http://bit.ly/MidasLetterInsta 

Like Us on Facebook: 
http://bit.ly/MidasLetterFacebook

************************

#CannTab
#Cannabis
#WeedStocks

More from this channel